Reported 2 days ago
Merus N.V. (NASDAQ: MRUS) experienced a 7.75% decline in stock price on Wednesday, ending at $57.58, as the company announced a $300-million follow-on offering. This move raised concerns among investors about potential dilution of existing shares. The funds raised will support the clinical development of its product candidates and general corporate purposes.
Source: YAHOO